M
Maze Therapeutics, Inc. (MAZE)
NGM – Real Time Price. Currency in USD
26.99
-0.32 (-1.17%)
Market open: Aug 12, 2026, 10:19 AM EDT
27.50
+0.19 (0.70%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
26.99
-0.32 (-1.17%)
Market open: Aug 12, 2026, 10:19 AM EDT
27.50
+0.19 (0.70%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
| Breakdown | |
|---|---|
| 1.46% | % of Shares Held by All Insider |
| 99.06% | % of Shares Held by Institutions |
| 100.53% | % of Float Held by Institutions |
| 222 | Number of Institutions Holding Shares |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 4.57M | 2026-03-31 | 8.25% | $130.85M |
| TRV GP IV, LLC | 4.47M | 2026-03-31 | 8.08% | $128.18M |
| Arch Venture Management, Llc | 4.12M | 2026-03-31 | 7.44% | $118.04M |
| Deep Track Capital, Lp | 3.48M | 2026-03-31 | 6.28% | $99.63M |
| Janus Henderson Group PLC | 2.86M | 2026-03-31 | 5.17% | $81.91M |
| Paradigm Biocapital Advisors LP | 2.74M | 2026-03-31 | 4.96% | $78.63M |
| Blackrock Inc. | 2.57M | 2026-03-31 | 4.64% | $73.64M |
| a16z Capital Management, L.L.C. | 1.70M | 2026-03-31 | 3.08% | $48.77M |
| Venrock Adviser, LLC | 1.60M | 2026-03-31 | 2.89% | $45.90M |
| Vanguard Capital Management LLC | 1.44M | 2026-03-31 | 2.59% | $41.13M |
| Alphabet Inc. | 1.39M | 2026-03-31 | 2.51% | $35.49M |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.16M | 2026-03-31 | 2.10% | $33.30M |
| iShares Trust-iShares Russell 2000 ETF | 925,795 | 2026-06-30 | 1.67% | $26.52M |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 739,660 | 2026-06-30 | 1.34% | $21.19M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 324,041 | 2025-12-31 | 0.59% | $7.64M |
| iShares Trust-iShares Russell 2000 Growth ETF | 275,016 | 2026-06-30 | 0.50% | $7.88M |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 265,830 | 2026-06-30 | 0.48% | $7.62M |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 265,458 | 2026-05-31 | 0.48% | $7.61M |
| iShares Trust-iShares Biotechnology ETF | 245,303 | 2026-06-30 | 0.44% | $7.03M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 234,961 | 2026-03-31 | 0.42% | $6.73M |
| iShares Trust-iShares Russell 2000 Value ETF | 215,773 | 2026-05-31 | 0.39% | $5.97M |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 184,453 | 2026-05-31 | 0.33% | $5.28M |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 144,819 | 2026-06-30 | 0.26% | $4.15M |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 135,859 | 2026-05-31 | 0.25% | $3.75M |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 128,000 | 2026-02-28 | 0.26% | $3.45M |
| abrdn Healthcare Investors | 111,766 | 2026-03-31 | 0.20% | $3.05M |